Chan HL - Search Results

1

Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study.

Seto WK, Hui AJ, Wong VW, Wong GL, Liu KS, Lai CL, Yuen MF, Chan HL. Seto WK, et al. Among authors: chan hl. Gut. 2015 Apr;64(4):667-72. doi: 10.1136/gutjnl-2014-307237. Epub 2014 May 15. Gut. 2015. PMID: 24833635

2

Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus-infected patients.

Chan HL, Hui Y, Leung NW, Ching JY, Chan FK, Sung JJ. Chan HL, et al. Among authors: chan fk. Am J Gastroenterol. 2000 Dec;95(12):3547-51. doi: 10.1111/j.1572-0241.2000.03373.x. Am J Gastroenterol. 2000. PMID: 11151891

3

The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis.

Chan HL, Tang JL, Tam W, Sung JJ. Chan HL, et al. Aliment Pharmacol Ther. 2001 Dec;15(12):1899-905. doi: 10.1046/j.1365-2036.2001.01135.x. Aliment Pharmacol Ther. 2001. PMID: 11736720

4

Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.

Chan HL, Tsang SW, Liew CT, Tse CH, Wong ML, Ching JY, Leung NW, Tam JS, Sung JJ. Chan HL, et al. Am J Gastroenterol. 2002 Feb;97(2):406-12. doi: 10.1111/j.1572-0241.2002.05478.x. Am J Gastroenterol. 2002. PMID: 11866280

5

A cirrhotic patient with fever and abdominal pain in the presence of ascites.

Wong VW, Chan HL. Wong VW, et al. Among authors: chan hl. Hosp Med. 2003 May;64(5):310. doi: 10.12968/hosp.2003.64.5.1768. Hosp Med. 2003. PMID: 12789745 No abstract available.

6

Use of hepatitis B virus DNA quantitation to predict hepatitis B e antigen reversion in cases of chronic hepatitis B.

Chan HL, Wong ML, Hui AY, Hung LC, Chan FK, Sung JJ. Chan HL, et al. Among authors: chan fk. J Clin Microbiol. 2003 Oct;41(10):4793-5. doi: 10.1128/JCM.41.10.4793-4795.2003. J Clin Microbiol. 2003. PMID: 14532223 Free PMC article.

7

Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment.

Chan HL, Wong ML, Hui AY, Chim AM, Tse AM, Hung LC, Chan FK, Sung JJ. Chan HL, et al. Among authors: chan fk. World J Gastroenterol. 2003 Dec;9(12):2695-7. doi: 10.3748/wjg.v9.i12.2695. World J Gastroenterol. 2003. PMID: 14669315 Free PMC article. Clinical Trial.

8

Molecular virology in chronic hepatitis B: genotypes.

Wong GL, Chan HL. Wong GL, et al. Among authors: chan hl. Hosp Med. 2005 Jan;66(1):13-6. doi: 10.12968/hmed.2005.66.1.17529. Hosp Med. 2005. PMID: 15686160 Review.

9

A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.

Chan HL, Leung NW, Hui AY, Wong VW, Liew CT, Chim AM, Chan FK, Hung LC, Lee YT, Tam JS, Lam CW, Sung JJ. Chan HL, et al. Among authors: chan fk. Ann Intern Med. 2005 Feb 15;142(4):240-50. doi: 10.7326/0003-4819-142-4-200502150-00006. Ann Intern Med. 2005. PMID: 15710957 Clinical Trial.

10

Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model.

Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, Sung JJ. Hui AY, et al. Among authors: chan hl, chan fk. Am J Gastroenterol. 2005 Mar;100(3):616-23. doi: 10.1111/j.1572-0241.2005.41289.x. Am J Gastroenterol. 2005. PMID: 15743360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,246 results

Search Page

Filters